Medicinal Product Regulation and Product Liability in South Africa
Medicinal product regulation and product liability in South Africa: overview by Danie Dohmen, Jenny Pienaar, Alexis Apostolidis and Jeanette Visagie
A Q&A guide to medicinal product regulation and product liability law in South Africa.
The Q&A gives a high level overview of key issues including pricing and state funding, manufacturing, marketing, clinical trials, advertising, labelling, and product recall and liability.
To read the full Q&A, visit Thomsan Reuters Practical Law.
For information on pharmaceutical patents, trade marks, competition law, patent licensing, generic entry, abuse of dominance and parallel imports, visit Pharmaceutical IP and Competition Law in South Africa: overview.
AFCON Eliminations: Celebrating African Football and Intellectual Property Development
The Africa Cup of Nations (AFCON) Round of 16 and quarterfinals have concluded, with eight nations exiting the tournament: Algeria, Benin, Burkina Faso, Cameroon, Côte d’Ivoire (Ivory Coast), DR Co...
January 14 2026
NAVIGATING ZAMBIA’S NEW TRADE MARKS ACT: PRACTICAL INSIGHTS FOR TRADE MARK PROSECUTION
On 31 December 2025, Zambia ushered in a new era for trade mark protection with the enactment of Trade Marks Act No. 11 of 2023 (the Act), following the signing of Statutory Instrument No. 86 of 2025....
January 12 2026
Adams & Adams AntiCounterfeiting Team strikes another major blow against counterfeit lubricant manufacturers
Adams & Adams’ AntiCounterfeiting Team has recently conducted another successful major operation targeting the manufacture, production, and distribution of counterfeit engine and gearbox lubri...
January 09 2026

